Preclinical Study Data on TTX-MC138 for Glioblastoma Accepted for Publication
source: shutterstock.com

Preclinical Study Data on TTX-MC138 for Glioblastoma Accepted for Publication

TransCode Therapeutics, Inc. (“TransCode”) was founded with a mission to revolutionize the cancer treatment landscape and improve patient outcomes. The company is currently working to uphold this mission through the…

Continue Reading Preclinical Study Data on TTX-MC138 for Glioblastoma Accepted for Publication
Glioblastoma: Current Therapies and Recent Therapeutic Advances
source: pixabay.com

Glioblastoma: Current Therapies and Recent Therapeutic Advances

Republished with permission from Personalize My Medicine, a Patient Worthy partner organization.  Written by Eleanor Doherty Glossary Antibody, Antidepressant, Antigen, Apoptosis, Astrocyte, CAR-T Cell Therapy, Atypia, Clinical Trial, CNS, Dendritic Cell Vaccine, Epidermal Growth Factor, Ex-Vivo, Glioblastoma Multiforme, Glioma, Immunotherapy, Metastasis, Mitotic Activity, Monoclonal Antibody, Necrosis, Neuron, Neurotransmitter, Oncology, Oncolytic Virotherapy, Prognosis, Radiotherapy, Stem Cell, Surgical…

Continue Reading Glioblastoma: Current Therapies and Recent Therapeutic Advances
Researchers Discover a Method to Cross the Blood-Brain Barrier and Treat Lethal Tumors
source: pixabay.com

Researchers Discover a Method to Cross the Blood-Brain Barrier and Treat Lethal Tumors

  Researchers at Brown University, in collaboration with an MIT research team, discovered a method of penetrating the blood-brain barrier (BBB) in mice and delivering medication to treat lethal tumors…

Continue Reading Researchers Discover a Method to Cross the Blood-Brain Barrier and Treat Lethal Tumors

Editor’s Choice: A New Dystonia Center of Excellence, A Call for Sickle Cell Blood Donors, and a New Treatment Target for Glioblastoma

Happy Friday! A tropical storm system will be traveling up through the mid-Atlantic this weekend, bringing wind and rain. Hunker down! This week, we have stories on Duke University being…

Continue Reading Editor’s Choice: A New Dystonia Center of Excellence, A Call for Sickle Cell Blood Donors, and a New Treatment Target for Glioblastoma
Dallas University Researcher and Colleagues Create a Molecule That Kills a Wide Range of Treatment-Resistant Cancers
source: pixabay.com

Dallas University Researcher and Colleagues Create a Molecule That Kills a Wide Range of Treatment-Resistant Cancers

  Dr. Jung-Mo Ahn, associate professor at Dallas University in Texas, created a molecule that kills a broad range of treatment-resistant cancers. The newly targeted group includes triple-negative breast cancer.…

Continue Reading Dallas University Researcher and Colleagues Create a Molecule That Kills a Wide Range of Treatment-Resistant Cancers
Former Resident of Woodbridge, New Jersey Calls for Action After Learning of Sixty-Five Rare Brain Tumors Linked to Local High School
source: pixabay.com

Former Resident of Woodbridge, New Jersey Calls for Action After Learning of Sixty-Five Rare Brain Tumors Linked to Local High School

  Al Lupiano, an environmental scientist, recently spoke with Meg Baker of CBS2. Al told her that twenty years ago, he was diagnosed with a brain tumor. The memory and…

Continue Reading Former Resident of Woodbridge, New Jersey Calls for Action After Learning of Sixty-Five Rare Brain Tumors Linked to Local High School

Virginia Tech’s Carilion School of Medicine Has Put a Special Focus on Rare Disease

Currently, 95% of rare diseases don't have an effective treatment. Progress is being made, but there is just so much ground to cover in rare disease research. Studying rare diseases…

Continue Reading Virginia Tech’s Carilion School of Medicine Has Put a Special Focus on Rare Disease